These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
580 related items for PubMed ID: 23213079
1. Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer. Stephan C, Jung K, Semjonow A, Schulze-Forster K, Cammann H, Hu X, Meyer HA, Bögemann M, Miller K, Friedersdorff F. Clin Chem; 2013 Jan; 59(1):280-8. PubMed ID: 23213079 [Abstract] [Full Text] [Related]
2. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Tomlins SA, Day JR, Lonigro RJ, Hovelson DH, Siddiqui J, Kunju LP, Dunn RL, Meyer S, Hodge P, Groskopf J, Wei JT, Chinnaiyan AM. Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884 [Abstract] [Full Text] [Related]
3. Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. Salami SS, Schmidt F, Laxman B, Regan MM, Rickman DS, Scherr D, Bueti G, Siddiqui J, Tomlins SA, Wei JT, Chinnaiyan AM, Rubin MA, Sanda MG. Urol Oncol; 2013 Jul; 31(5):566-71. PubMed ID: 21600800 [Abstract] [Full Text] [Related]
11. Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer. Stephan C, Vincendeau S, Houlgatte A, Cammann H, Jung K, Semjonow A. Clin Chem; 2013 Jan; 59(1):306-14. PubMed ID: 23213080 [Abstract] [Full Text] [Related]
13. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy. De Luca S, Passera R, Bollito E, Manfredi M, Scarpa RM, Sottile A, Randone DF, Porpiglia F. Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144 [Abstract] [Full Text] [Related]
14. Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Tomlins SA, Aubin SM, Siddiqui J, Lonigro RJ, Sefton-Miller L, Miick S, Williamsen S, Hodge P, Meinke J, Blase A, Penabella Y, Day JR, Varambally R, Han B, Wood D, Wang L, Sanda MG, Rubin MA, Rhodes DR, Hollenbeck B, Sakamoto K, Silberstein JL, Fradet Y, Amberson JB, Meyers S, Palanisamy N, Rittenhouse H, Wei JT, Groskopf J, Chinnaiyan AM. Sci Transl Med; 2011 Aug 03; 3(94):94ra72. PubMed ID: 21813756 [Abstract] [Full Text] [Related]
16. Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy. De Luca S, Passera R, Fiori C, Bollito E, Cappia S, Mario Scarpa R, Sottile A, Franco Randone D, Porpiglia F. Urol Oncol; 2015 Oct 03; 33(10):424.e17-23. PubMed ID: 26162485 [Abstract] [Full Text] [Related]